Thiomers: Promising Platform For Macromolecular Drug Delivery
- 29 November 2012
- journal article
- review article
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 4 (17) , 2205-2216
Abstract
The application of macromolecules as therapeutic agents holds great promise for several major disorders such as cancer and cardiovascular disease. However, their use is limited by the lack of efficient, safe and specific delivery strategies. A promising strategy to overcome these challenges might be the use of thiolated polymers or designated thiomers. Thiomers are synthesized by immobilization of sulfhydryl bearing ligands on a polymeric backbone of well-established polymers. These multifunctional polymeric excipients show advantages in mucoadhesion, enzyme and efflux pump inhibition in comparison to unmodified polymers. One obstacle in the use of thiomers is that they are prone to oxidation at lower pH but this could be solved by introducing a completely new generation of thiomers, namely, the preactivated thiomer generation. Preactivated thiomers are mixed disulfides, which exhibit oxidation resistance and, beyond that, improved thiomer features. This review summarizes recent findings of polymeric exci...Keywords
This publication has 72 references indexed in Scilit:
- Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin deliveryEuropean Journal of Pharmaceutical Sciences, 2011
- Recent Advancement of Chitosan-Based Nanoparticles for Oral Controlled Delivery of Insulin and Other Therapeutic AgentsAAPS PharmSciTech, 2010
- In situ gelling properties of chitosan-thioglycolic acid conjugate in the presence of oxidizing agentsBiomaterials, 2009
- Emerging implications of nanotechnology on cancer diagnostics and therapeuticsCancer, 2006
- Protective efficiency of dendrosomes as novel nano-sized adjuvants for DNA vaccination against birch pollen allergyJournal of Biotechnology, 2006
- A New Polymer–Lipid Hybrid Nanoparticle System Increases Cytotoxicity of Doxorubicin Against Multidrug-Resistant Human Breast Cancer CellsPharmaceutical Research, 2006
- Nanosuspension Formulations for Low-Soluble Drugs: Pharmacokinetic Evaluation Using Spironolactone as Model CompoundDrug Development and Industrial Pharmacy, 2005
- Nanoparticle and targeted systems for cancer therapyAdvanced Drug Delivery Reviews, 2004
- Multifunctional Matrices for Oral Peptide DeliveryCritical Reviews™ in Therapeutic Drug Carrier Systems, 2001
- Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEuropean Journal of Pharmaceutics and Biopharmaceutics, 2000